Point72 Hong Kong’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,559
| Closed | -$107K | – | 483 |
|
|
2024
Q1 | $107K | Buy |
+2,559
| New | +$107K | 0.01% | 419 |
|
|
2022
Q2 | – | Sell |
-1,394
| Closed | -$47K | – | 1507 |
|
|
2022
Q1 | $47K | Buy |
1,394
+511
| +58% | +$17.2K | ﹤0.01% | 860 |
|
|
2021
Q4 | $34K | Sell |
883
-2,337
| -73% | -$90K | ﹤0.01% | 887 |
|
|
2021
Q3 | $174K | Buy |
+3,220
| New | +$174K | 0.01% | 606 |
|
|
2018
Q3 | – | Sell |
-812
| Closed | -$6K | – | 925 |
|
|
2018
Q2 | $6K | Buy |
812
+776
| +2,156% | +$5.73K | ﹤0.01% | 688 |
|
|
2018
Q1 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 822 |
|
|
2017
Q4 | – | Sell |
-36
| Closed | -$2K | – | 875 |
|
|
2017
Q3 | $2K | Buy |
+36
| New | +$2K | ﹤0.01% | 641 |
|
|
2017
Q1 | – | Sell |
-36
| Closed | -$2K | – | 758 |
|
|
2016
Q4 | $2K | Buy |
+36
| New | +$2K | ﹤0.01% | 770 |
|